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Abstract. 
 
The association of pericytes (PCs) to newly
formed blood vessels has been suggested to regulate
endothelial cell (EC) proliferation, survival, migration,
differentiation, and vascular branching. Here, we ad-
dressed these issues using PDGF-B– and PDGF recep-
tor-
 
b 
 
(PDGFR-
 
b
 
)–deﬁcient mice as in vivo models of
brain angiogenesis in the absence of PCs. Quantitative
morphological analysis showed that these mutants have
normal microvessel density, length, and number of
branch points. However, absence of PCs correlates with
endothelial hyperplasia, increased capillary diameter,
abnormal EC shape and ultrastructure, changed cellu-
lar distribution of certain junctional proteins, and mor-
phological signs of increased transendothelial perme-
ability. Brain endothelial hyperplasia was observed
already at embryonic day (E) 11.5 and persisted
throughout development. From E 13.5, vascular endo-
thelial growth factor-A (VEGF-A) and other genes re-
sponsive to metabolic stress became upregulated, sug-
gesting that the abnormal microvessel architecture has
systemic metabolic consequences. VEGF-A upregula-
tion correlated temporally with the occurrence of vas-
cular abnormalities in the placenta and dilation of the
heart. Thus, although PC deﬁciency appears to have di-
rect effects on EC number before E 13.5, the subse-
quent increased VEGF-A levels may further abrogate
microvessel architecture, promote vascular permeabil-
ity, and contribute to formation of the edematous
phenotype observed in late gestation PDGF-B and
PDGFR-
 
b
 
 knock out embryos.
Key words: mice • angiogenesis • pericytes • platelet-
derived growth factor B • vascular endothelial growth
factor
 
Introduction
 
The vascular system is the first functional organ in the de-
veloping vertebrate embryo and its continuous growth is
required for embryonic development. The first blood ves-
sels develop from mesenchymal cells that differentiate
into endothelial tubes and interconnect to form a primitive
blood vessel network. New blood vessels develop from this
vascular plexus by angiogenesis, which comprises endothe-
lial sprouting, splitting, and fusion (Risau, 1997). Soon af-
ter the first endothelial tubes have formed, they become
associated with mural cells of the smooth muscle cell lin-
eage, referred to as pericytes (PCs)
 
1
 
 or vascular smooth
muscle cells (vSMCs) (Sims, 1986).
The PC/vSMCs are probably induced de novo from the
mesenchyme surrounding the endothelium (Beck and
D’Amore, 1997). In vitro experiments implicate TGF-
 
b
 
 in
this process (Antonelli-Orlidge et al., 1989; Sato and
Rifkin, 1989; Hirschi et al., 1998). In addition, targeted
mutagenesis in mice implicates TGF-
 
b
 
 signaling in the
process of PC/vSMC development (Li et al., 1999; Yang et
al., 1999; Oh et al., 2000). An early role for angiopoietin-1
and its receptor Tie-2 in the formation of PC/vSMCs is
suggested from the phenotypes of angiopoietin-1 and
Tie-2 knock outs, which both exhibit reduced embryonic
PC/vSMC formation (Suri et al., 1996; Patan, 1998). In ad-
dition, humans with a point mutation in the 
 
tie-2
 
 gene acti-
vating its tyrosine kinase exhibit venous malformations
with regionally reduced vSMC coating (Vikkula et al.,
1996).
After induction, the population of PC/vSMCs is ex-
panded and recruited to angiogenic sprouts by means of
proliferation and migration (Nicosia and Villaschi, 1995;
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Beck and D’Amore, 1997; Benjamin et al., 1998). This lon-
gitudinal
 
 
 
spreading of PC/vSMCs along growing blood
vessels depends on PDGF-B and PDGF receptor-
 
b
 
(PDGFR-
 
b
 
) (Lindahl et al., 1997; Hellstrom et al., 1999).
In the developing mouse embryo, PDGF-B is produced by
the endothelium, whereas PDGFR-
 
b
 
 is expressed by de-
veloping PC/vSMCs (Holmgren et al., 1991; Lindahl et al.,
1997). Targeted disruption of PDGF-B or PDGFR-
 
b
 
genes both lead to formation of blood vessels lacking PC/
vSMCs. Chimeric analysis of wild-type and PDGFR-
 
b
 
–null
cells has shown that PDGFR-
 
b
 
 is cell autonomously
required in the PC/vSMC lineage (Crosby et al., 1998;
Lindahl et al., 1998). Together, these data suggest that lon-
gitudinal recruitment of PC/vSMCs is controlled by para-
crine signaling involving PDGF-B released from endo-
thelial cells (ECs) to act on PDGFR-
 
b
 
 expressed by
neighboring PC/vSMCs.
The PDGF-B– and PDGFR-
 
b
 
–null mutations are ho-
mozygously lethal at birth. The immediate cause of le-
thality appears to be a sudden onset of microvascular
hemorrhaging and edema formation. However, multiple
cardiovascular abnormalities are apparent from earlier
embryonic age, including cardiac dilation and hypertra-
beculation, abnormal kidney glomeruli lacking mesangial
cells, an abnormal placenta labyrinthine layer, and dilation
of large and small caliber blood vessels (Levéen et al.,
1994; Soriano, 1994; Lindahl et al., 1997; Hellstrom et al.,
1999; Ohlsson et al., 1999). The microvascular hemorrhag-
ing is preceded by the formation of microaneurysms,
which are morphologically similar to the characteristic le-
sions in human diabetic microangiopathy (Cogan et al.,
1961). It is possible that all phenotypes observed in
PDGF-B and PDGFR-
 
b
 
 knock outs are caused by a re-
duction in the abundance of PC/vSMCs, but both the nor-
mal role of PCs in microvessels and the pathogenesis of
the cardiovascular changes in PDGF-B and PDGFR-
 
b
 
knock outs remain unclear. It is likely, however, that PCs
influence EC behavior. PCs have been suggested to have a
role in endothelial sprouting, and the localization of PCs
to capillary branch points suggests a role in vascular
branching morphogenesis (Nehls et al., 1994). It has been
proposed that PCs negatively regulate EC proliferation in
vitro (Orlidge and D’Amore, 1987; Hirschi et al., 1999).
On the other hand, PCs appear to promote EC survival in
the pruning process during formation of the retinal vascu-
lature and in tumor vessels after experimental withdrawal
of the vascular endothelial growth factor-A (VEGF-A)
(Benjamin et al., 1998, 1999). Based on these findings, the
lack of PCs in vivo would either be predicted to lead to an
increase in EC proliferation, resulting in EC hyperplasia,
or to a decreased EC survival, resulting in EC hypoplasia.
Although mechanistically conflicting, both results could
lead to vascular dysfunction and cause the phenotypes ob-
served in PDGF-B– and PDGFR-
 
b
 
–null embryos. The
present investigation addresses the role of PCs making
use of the unique properties of PDGF-B– and PDGFR-
 
b
 
–deficient mice as an in vivo model of brain angiogenesis
in the absence of PCs (Lindahl et al., 1997; Hellstrom et
al., 1999). We show that PCs are not determining mi-
crovessel density, length, or branching, but are involved in
the regulation of EC number and morphology and mi-
crovessel architecture.
 
Materials and Methods
 
Animals
 
Mice harboring the deletion of the PDGF-B and PRDGFR-
 
b
 
 genes were
bred as heterozygous outbred hybrids of 129/sv and C57Bl6 (Levéen et al.,
1994; Soriano, 1994). Ages of embryos subject to analysis were given as
embryonic day (E) where the vaginal plug was scored on E 0.5 and birth
usually took place on E 19. The indicated number of embryos of the dif-
ferent genotypes (wild type, PDGF-B knock outs, PDGFR-
 
b
 
 knock outs)
were used for each type of analysis below. EC quantification: E 10.5 (2, 2,
2), E 11.5 (5, 3, 2), E 12.5 (2, 2, 0), E 14.5 (2, 2, 0), E 16.5 (2, 3, 0), E 18.5 (2,
2, 2). Capillary morphometry: E 17.5 (2, 0, 2). Immunohistochemistry: E
18.5 (2, 2, 2), E 12.5 (2, 2, 2). Electron microscopy: E 18.5 (3, 4, 0).
VEGFA measurements (figures indicate number of samples analyzed
from head or brain/liver): E 12.5 (4/3, 5/2, 2/0), E 13.5 (4/10, 2/5, 2/5), E
14.5 (3/3, 3/3, 1/1), E 16.5 (3/2, 3/3, 3/2), E 18.5 (3/2, 4/4, 4/4). RNA analy-
sis: E 17.5 (3, 0, 3).
 
EC Quantification and Capillary Morphometry
 
Capillary EC nuclei were counted on 5-
 
m
 
m paraffin sections of brains
fixed in 4% paraformaldehyde. Sections were stained with propidium io-
dide and biotinylated isolectin BS-I (L-2140; Sigma-Aldrich) as described
(Hellstrom et al., 1999), except for the use of streptavidin Alexa 488
(S-11223; Molecular Probes) at a final concentration of 2 
 
m
 
g/ml. EC nuclei
were counted using the 60
 
3
 
 objective on a Nikon Eclipse E1000 micro-
scope with a fluorescent filter allowing simultaneous monitoring of red
and green signals. For morphometric analysis, 14-
 
m
 
m sections were stained
with isolectin BS-I and horseradish peroxidase (Hellstrom et al., 1999) and
analyzed using the 10
 
3
 
 objective on an Optronics charge-coupled device
camera and associated software. Capillary blood vessel length and branch-
ing were quantified on 15 photographic areas. The capillary diameter was
quantified on 15 photographic areas at 200 sites.
 
Immunohistochemistry
 
The following antibodies were used at the dilutions indicated: polyclonal
rabbit anticaveolin-1 (1:500; Transduction Laboratories), polyclonal rab-
bit antiaquaporin-4 (1:100; Chemicon), polyclonal rabbit anticlaudin-1
(1:500; Zymed), polyclonal rabbit antioccludin (1:200, clone Z-T22; Zymed),
polyclonal rabbit anti–ZO-1 (1:500; Zymed), rat monoclonal anti–VE-
cadherin (culture supernatant; provided by Dr. Dietmar Vestweber, Uni-
versity of Muenster, Muenster, Germany), FITC-conjugated polyclonal
sheep antifibronectin (1:100; Biotrend), polyclonal rabbit anticlaudin-5
(1:1,000; production described in Liebner et al., 2000). Embryonic brains
were dissected and directly frozen in Tissue-Tek OCT (Miles Scientific).
Cryosections were cut at 12 
 
m
 
m, mounted on glass slides, air dried, and
fixed in ice-cold ethanol for 5 min followed by 1 min in acetone at room
temperature. Sections were rinsed and incubated with the primary and ap-
propriate secondary antibodies as described (Gerhardt et al., 1996). Slides
were coverslipped using Moviol and analyzed using a Leica TCS NT con-
focal laser scanning microscope (Leica). For direct comparison between
wild-type and knock out brains, sections were mounted pairwise on the
slides. Photomultiplier settings were identical for image acquisition from
knock out and wild-type specimen.
 
Electron Microscopy
 
Embryos were fixed by perfusion through the heart of 2.5% glutaralde-
hyde in Hank’s modified salt solution buffer. Brains were immersion fixed
in the same fixative for an additional 4 h, washed, postfixed, dehydrated,
and processed for transmission electron microscopy as described (Ger-
hardt et al., 1996). For freeze fracture analysis, tissue specimens were fixed
as above, cryoprotected for freeze fracture in 30% glycerol, and frozen in
nitrogen slush (
 
2
 
210
 
8
 
C). Subsequent freeze fracture of the tissue and anal-
ysis by electron microscopy was done as described (Kniesel et al., 1996).
 
RNA Analyses
 
Total RNA was prepared from snap frozen brain tissue using the RNeasy
midi kit (75144; QIAGEN) according to the manufacturer’s protocol. For
Northern blot analysis, 10 
 
m
 
g RNA was used for Northern blot analysis by
the NorthernMax Kit (1940; Ambion). Mouse probes for 
 
b
 
-actin, GRP-78,
and glucose transporter 1 (Glut-1) and rat probes for phosphoglycerate ki-
nase (PGK) and lactate dehydrogynase (LDH; probes provided by Dr. 
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Peter Carmeliet, Center for Transgene Technology and Gene Therapy,
Leuven, Belgium) were randomly labeled using Megaprime DNA label-
ing system (RPN 1607; Amersham Pharmacia Biotech) according to the
manufacturer’s protocols. For RNase Protection analysis, 30 
 
m
 
g of RNA
was used in the RPA III kit (1414; Ambion), and polyacrylamide gels
were exposed and scanned using a BAS-1500 PhosphoImager (Fuji). Ri-
boprobes were prepared using RNA polymerase (Promega) and [
 
32
 
P]UTP
(Amersham Pharmacia Biotech) according to the manufacturer’s proto-
col. Mouse cDNA fragments used as templates to make the probes are as
follows: Flt-1, 437 bp, NM_002019.1; Tie1, EcoRI fragment of 
 
z
 
400 bp,
X80764; Flk-1, 725 bp, X70842. 
 
b
 
-Actin template (Ambion), which gener-
ates a 250-bp protected fragment, was used as an internal control for
quantification.
 
VEGF-A Measurements
 
Tissues were snap frozen and kept at 
 
2
 
80°C until analysis and subse-
quently lysed and homogenized in 150 mM NaCl, 66 mM EDTA, 10 mM
Tris-HCL (pH 7.4), 0,4% sodiumdeoxycholate, 1% NP-40, and protease
inhibitor cocktail (P-2714; Sigma-Aldrich). The VEGF-A ELISA detec-
tion kit (MMV00; R&D Systems) was used to quantify VEGF-A protein
from tissue lysates. The plates were read in a Kinetic microplate reader
(Molecular Devices). The VEGF-A concentration was normalized against
the total amount of protein in the sample using protein assay (500-0006;
Bio-Rad Laboratories).
 
Statistics and Image Processing
 
The two-tailed paired Student’s 
 
t
 
 test was used for all statistical calculation.
Pictures were assembled and processed in Adobe
 
®
 
 Photoshop™, v5.5.
 
Results
 
EC Hyperplasia in PDGF-B– and PDGFR-
 
b
 
–deficient 
Embryos Correlates with Lack of PCs in the Brain
 
We compared the number of ECs in the brains of wild-
type and PDGF-B and PDGFR-
 
b
 
 knock out embryos by
counting the number of EC nuclei per capillary cross sec-
tion (Fig. 1). The number of nuclei per cross section varied
throughout development and was higher at the earlier
time points (Fig. 1 b). There was an increase of 
 
z
 
60% in
the number of nuclei per capillary cross section in PDGF-B
and PDGFR-
 
b
 
 knock out brains from E 11.5 on (Fig. 1
c). This increase persisted throughout prenatal develop-
ment and correlated with the lack of PCs in the PDGF-B
and PDGFR-
 
b
 
 knock out brains seen at E 11.5 and
throughout prenatal development (Hellstrom et al., 1999;
data not shown). Studies of longitudinally sectioned capil-
laries and serial sections showed that EC nuclear shape
was not altered in mutants (not shown). Thus, an in-
creased nuclear count reflects EC hyperplasia. EC hyper-
plasia was not observed in the perineural vascular plexus
surrounding the brain (data not shown) where PCs are still
present in the PDGF-B and PDGFR-
 
b
 
 knock out embryos
(Lindahl et al., 1997; Hellstrom et al., 1999). BrdU and
TdT-mediated dUTP-biotin nick end labeling staining was
analyzed at several time points between E 10.5 and E 18.5,
but no significant differences between wild-type and mu-
tant embryos were revealed (data not shown). This ex-
cludes a simultaneous large increase in proliferation and
apoptosis, but the sensitivity of the analysis does not allow
small changes in cell number that may arise over several
cell cycles to be correctly determined.
To assess if the density and branching of vessels was af-
fected by PC absence, morphometric analysis was done of
closely matched photographic areas of E 17.5 brains from
wild-type and PDGFR-
 
b
 
 knock out embryos. There were
no significant changes in average total blood vessel length
(1.133 
 
6
 
 21 
 
m
 
m [SEM] per photographic area for wild type
and 1.118 
 
6
 
 23 
 
m
 
m for PDGFR-
 
b
 
 knock out). Also, the
numbers of blood vessel branch points were similar in wild
type and PDGFR-
 
b
 
 knock out (6.3 
 
6
 
 0.22 [SEM] per pho-
tographic area for wild type and 5.6 
 
6
 
 0.25 branch points
for PDGFR-
 
b
 
 knock out).
We performed RNase Protection assays for the endo-
thelial receptor tyrosine kinases VEGFR-1/Flt-1, VEGFR-
2/Flk-1, and Tie1 to assess if these transcripts were altered
in the mutants. Total RNA was analyzed at E 17.5 in the
wild-type and PDGFR-
 
b
 
 knock out brains and normalized
against 
 
b
 
-actin. In the PDGFR-
 
b
 
 knock out brain, the
VEGFR-1 signal was 146% compared with wild type (
 
p
 
-
value
 
 5 
 
0.077), VEGFR-2 signal was 179% compared with
Figure 1. EC quantification in wild type, PDGF-B, and PDGFR-b
knock out embryos. A brain capillary stained for isolectin BS-I
(staining EC, green) and propidium iodide (staining nuclei, red)
(a). The quantification of EC nuclei per vessel cross section in
wild type, PDGF-B2/2, and PDFGFR-b2/2 is shown in b, and the
values for the mutants are shown as a percentage of the wild type
in c. There is a prominent EC hyperplasia from E 11.5 on in the
PDGF-B and PDGFR-b knock outs. The error bars represent
the SEM. PDGF-B and PDGFR-b knock out values were signifi-
cantly different (p-value , 0.001) from the wild-type values at E
11.5, 12.5, 13.5, 14.5, 16.5, and 18.5, but not at E 10.5. Bar, 10 mm. 
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wild type (
 
p
 
-value
 
 5
 
 0.002), and Tie1 signal was 259%
compared with wild type (
 
p
 
-value
 
 5
 
 0.02). There is good
correlation between the magnitudes of the expression of
VEGFR-1 and -2 and the EC hyperplasia, suggesting that
the expression of VEGFR-1 and -2 is not altered in the ab-
sence of PCs. The larger increase in Tie1 compared with
VEGFR-1 and -2 expression in mutants is compatible with
a previous report that Tie1-driven LacZ expression is in-
creased in the PDGF-B knock out (Lindahl et al., 1997).
 
Abnormal Blood Vessel Morphogenesis in 
PDGF-B and PDGFR-
 
b
 
 Knock Outs
 
The EC hyperplasia prompted us to assess vessel diameter
and EC–EC interaction. The mean blood vessel diameter
was increased by 25% (
 
P
 
 , 
 
0.001) in the PDGFR-
 
b
 
 knock
out compared with wild type but was highly variable (Fig.
2 a). The blood vessels of the PDGF-B and PDGFR-
 
b
 
knock outs exhibited regional dilations along the blood
vessel length, which was not seen in the wild type. (Fig 2, b
and c; data not shown).
We used the tight junction marker ZO-1 to measure the
circumferential length of EC junctions at E 18.5, (Fig. 2, d
and e), a measure relating to the vessel surface occupied
by individual ECs. Vessel dilation without corresponding
increase in the number of ECs would lead to a larger mean
EC circumference. Circumferential length was, however,
reduced by 25% (
 
P
 
 , 
 
0.001) in the PDGFR-
 
b
 
 knock out,
suggesting less expanded ECs or a greater overlap be-
tween ECs, or possibly a combination of both. Thus, in
spite of vessel dilation in the knock outs, ECs were, on av-
erage, more densely packed in the capillary walls.
 
Increased Levels of VEGF-A in PDGF-B and
PDGFR-
 
b
 
 Knock Out Brains and Livers
 
We performed ELISA quantification of VEGF-A protein
in brain and liver at several time points throughout devel-
opment to determine its relation to EC hyperplasia in the
PDGF-B and PDGFR-
 
b
 
 knock out brains. The liver was
added to the analysis since liver PCs are recruited indepen-
dently of PDGF-B and PDGFR-
 
b
 
 (Hellstrom et al., 1999).
In PDGF-B and PDGFR-
 
b
 
 knock outs, VEGF-A levels
were progressively increased in both the brain and the liver
from E 13.5 until birth (Fig. 3, a and b). By Northern blot
analysis, the VEGF-A RNA level was also upregulated at
E 16.5 in the PDGF-B knock out (data not shown).
 
Increased Expression of Genes Responsive to Metabolic 
Stress in PDGF-B Knock Out Brains
 
Since VEGF-A expression is influenced by metabolic
stress such as hypoxia and hypoglycemia, we analyzed the
relative levels of several other transcripts responsive to
such stress: Glut-1, glucose-regulated protein 78, LDH,
and PGK. Northern blot analysis revealed an approxi-
mately twofold upregulation of all these genes in PDGF-B
knock out compared with wild-type and heterozygous E
16.5 brains (Fig. 4; data not shown). This indicates that the
PDGF-B knock out embryos suffer from metabolic stress,
which could be an important determinant of the increased
VEGF-A expression in mutant embryos.
Figure 2. Vessel diameter and EC tight junction length in wild
type and PDGFR-b knock out brains. Vessel diameter was mea-
sured on photographic areas from brain sections in wild type and
PDGFR-b–deficient embryos at 200 locations each (a). The mean
diameter was 4.0 6 1.4 mm (SD) in the wild-type and 5.0 6 2.8
mm in the PDGFR-b knock out embryos. There was a consider-
able variation of the diameter in the PDGFR-b knock out values
(a), which was also seen at the microscopic level in a comparison
between wild-type (b) and PDGF-B knock out (c) vessels. The
vessels in the PDGF-B knock out embryos exhibited large differ-
ences in the vessel diameter with local severe dilations (arrows),
whereas the wild-type vessels were more homogeneous in size.
The circumferential length of 100 EC junctions (ZO-1 staining,
red) were measured, as marked in d, in wild-type and PDGFR-b
knock out vessels (e). The mean circumferential length was 44 6
21 mm (SD) in the wild type and 33 6 mm 26 in the PDGFR-b
knock out. Bar, 10 mm.Hellström et al. Vascular Morphogenesis in the Absence of Pericytes 547
Abnormal Ultrastructural EC Morphology and 
Increased Caveolae Formation in PDGF-B and 
PDGFR-b Knock Out Brains
The morphological appearance of differentiated ECs is
highly organized. The luminal surface is smooth, and the
cytoplasmic thickness is uniform (Fig. 5, a and c). The ul-
trastructural analysis of PDGF-B knock out brain at E 17.5
revealed a highly abnormal EC morphology (Fig. 5, b and
d). The luminal surface had multiple processes projecting
into the lumen of the vessel (Fig. 5 d). In contrast to the
wild type, the thickness of the knock out endothelium var-
ied considerably (Fig. 5, b and d). In some areas, the cyto-
plasm of the cells was extremely thin, whereas at other
sites it was considerably thicker than wild type. Another
prominent feature of the PDGF-B knock out endothelium
was the increase in the number of caveolae, which are vesi-
cles involved in fluid and macromolecular transport across
the endothelium (Figs. 5, e–h, and 6, a and b). Quantifica-
tion revealed a 2.5-fold increase in the number of caveolae
(counting caveolae per micrometer of vessel perimeter on
electron micrographs at 30,0003 magnification, 50 mi-
crovessels; data not shown). Consistent with an increase of
fluid transport, many glia cells juxtaposed to the ECs of
the PDGF-B knock out vessels exhibited prominent swell-
ing, which was not seen in the wild type (Fig 6 d).
Increased Immunostaining for Caveolin-1 
and Aquaporin-4 in PDGF-B and PDGFR-b 
Knock Out Brains
Caveolae in ECs are marked by the protein caveolin-1 (for
review see Parton, 1996). Therefore, caveolin-1 immu-
nostaining was carried out to determine whether the in-
creased number of caveolae was also accompanied by cor-
responding increase in caveolin-1 labeling. Confocal laser
scanning microscopy of PDGFR-b knock out brain endo-
thelium showed an increased punctuate caveolin-1 staining
(Fig. 6, a and b). However, in the highly permeable vessels
of the choroid plexus, both the wild type and the PDGFR-b
knock out exhibited equally high expression levels (Fig. 6,
c and d). To assess if the glial swelling was accompanied by
alterations in staining for water channel proteins, we im-
munolabeled aquaporin-4, which, in the brain, is specifi-
cally expressed by astrocytic cells. Aquaporin-4 revealed a
heterogeneous staining but prominent upregulation in the
immediate proximity of highly abnormal blood vessels in
the PDGFR-b knock out (Fig. 6, e and f). Similar changes
in caveolin-1 and aquaporin-4 expression were found in
PDGF-B knock outs (data not shown).
Redistribution of VE-Cadherin and Occludin in ECs of 
PDGF-B and PDGFR-b Knock Out Brains
To further analyze the basis for vascular leakage in
PDGF-B and PDGFR-b knock outs, we performed a de-
tailed analysis of adherens and tight junction proteins by
immunolabeling and confocal laser scanning microscopy.
VE-cadherin, the major cadherin involved in EC–EC con-
tact (Breier et al., 1996; Navarro et al., 1998), exhibited re-
duced junctional staining and increased cytoplasmic distri-
bution in the PDGFR-b knock out compared with wild
type at E 18.5 (Fig. 7, a and b), but no difference was seen
at E 12.5 (data not shown). Occludin, an integral part of
the tight junction (Furuse et al., 1993), showed less distinct
junctional staining in PDGFR-b knock out ECs compared
with wild type at E 18.5 (Fig. 7, d and e). This difference
was not seen at E 12.5 (data not shown). Similar changes
in cellular distribution of VE-cadherin and occludin were
found in brain vessels of E 18.5 PDGF-B knock outs (data
not shown). Analysis of the tight junction proteins ZO-1
and claudin-1 and -5 revealed no differences in junctional
localization or staining intensity in PDGF-B or PDGFR-b
knock outs at E 18.5 or E 12.5 (Fig. 7, g and h; data not
Figure 3. A time course of VEGF-A ELISA measurements.
VEGF-A levels were upregulated from E 13.5 on in both PDGF-B
and PDGFR-b knock out head/brain (a) and liver (b). The
VEGF-A concentration was normalized against the total protein
in the tissue sample. There were no significant differences be-
tween PDGF-B and PDGFR-b knock out values. The SEM is
shown as error bars.
Figure 4. Northern blot anal-
ysis of mRNAs regulated by
hypoxia, hypoglycemia, and
metabolic stress. Brain total
RNA from wild type, PDGF-
B1/2, and PDGF-B2/2 were
analyzed by Northern blot
for Glut-1, glucose-regu-
lated protein 78, LDH, and
PGK.  b-Actin was used as an
internal control. The PDGF-B
knock out brain showed
upregulation of all these
transcripts, especially LDH
and PGK.The Journal of Cell Biology, Volume 153, 2001 548
shown). The microaneurysms typical for the PDGF-B and
PDGFR-b knock out brains exhibited highly abnormal
staining for all the above mentioned proteins (Fig. 7, c, f,
and i), most likely coupled to the extreme endothelial
morphology at these sites.
Alterations in the permeability of endothelial tight junc-
tions correlate with characteristic morphological changes
on freeze fracture images (for review see Kniesel and Wol-
burg, 2000). Upon cleavage of the two-cell membrane leaf-
lets, the tight junctional particles remain inserted in either
the external leaflet or in the protoplasmic leaflet, thus
leaving a pit on the corresponding fracture face. The rela-
tive amount of p-face–associated tight junction particles
Figure 5. Electron micrographs of brain capillaries in wild-type
(a and c) and PDGF-B knock out (b and d–h) embryos at E 18.5.
Capillaries in wild-type embryonic brains exhibited a smooth lu-
minal and abluminal endothelial surface and a homogenous
thickness of the endothelium (a and c), whereas those in PDGF-
B–deficient embryos were of highly variable thickness (b and d).
Luminal microfolds greatly enlarged the endothelial surface (d),
and perivascular glial swelling was prominent (star in d). Caveo-
lae were abundant in the endothelium of knock out embryos
(e–h), both near the luminal (arrows) and the abluminal surface
(boxed area, enlarged in g and h). In g, a series of caveolae ap-
peared almost to connect the luminal and the abluminal compart-
ment. Bars: (a and b) 10 mm; (c–f) 1 mm; (g and h) 100 nm.
Figure 6. Confocal laser scanning micrographs of double immu-
nolabeling for fibronectin (green) and caveolin-1 (a–d, red), and
for fibronectin (green) and aquaporin-4 (e and f, red) at E 18.5.
Caveolin-1 was considerably more abundant in brain capillaries of
PDGFR-b knock out mice (compare a with b). The highly perme-
able endothelium of the choroid plexus was strongly immunoposi-
tive for caveolin-1 in both wild-type (c) and knock out embryos
(d). In wild-type mice, aquaporin-4 labeling neatly outlined the
blood vessels (e, arrow) whereas it was widely distributed into
the surrounding brain parenchyma in knock out embryos (f, ar-
rows). Bars, 10 mm.Hellström et al. Vascular Morphogenesis in the Absence of Pericytes 549
reaches 55–60% in the mature mammalian blood–brain
barrier but lies considerably lower during embryonic de-
velopment (Kniesel et al., 1996). A second parameter of
tight junction integrity is the complexity of the junctional
network, reflecting the branching frequency of the tight
junctional strands. Freeze fracture analysis was therefore
performed on the tight junction of the vessels in the
PDGF-B knock out at E 18.5 but did not reveal any appar-
ent differences when compared with wild-type embryos
(Fig. 8, a and b). For both wild-type and knock out em-
bryos, the tight junctional appearance resembled that pub-
lished for embryonic rat brain endothelium at E 18 (Knie-
sel et al., 1996).
Discussion
It has previously been shown that PDGF-B is produced by
ECs and that PDGFR-b is present on PC/vSMCs
(Holmgren et al., 1991; Lindahl et al., 1997; Hellstrom et
al., 1999). PDGFR-b–negative cells fail to contribute to
the PC/vSMCs lineage in mouse chimeras but contribute
to the endothelium (Crosby et al., 1998; Lindahl et al.,
1998). The endothelial phenotypes observed in PDGF-B
and PDGFR-b knock outs are therefore most likely sec-
ondary to the lack of PCs along the vessels and may reflect
deficient paracrine/juxtacrine PC-to-EC signaling or in-
creased VEGF-A levels secondary to systemic metabolic
stress caused by dysfunction of the cardiovascular system
Figure 7. Confocal laser scanning micrographs of immunolabeling for VE-cadherin (a–c), occludin (d–f), and ZO-1 (g–i) at E 18.5.
(Left) Wild type. (Middle and right) PDGFR-b knock out. (Right) Show examples of brain microaneurysms with additional fibronectin
staining (green) to outline the vessels. In brain capillaries of wild type mice, VE-cadherin was largely confined to the interendothelial
junction (a, arrows), whereas in those of knock out embryos, VE-cadherin was more uniformly distributed (b and c). Arrow indicates
weak junctional labeling; arrowhead points to cytoplasmic labeling. Occludin labeling was also more diffuse in the knock out (compare
d with e; arrow, junctional labeling; arrowhead, cytoplasmic labeling). In microaneurysms, the occludin-positive junctional network was
discontinuous (f). ZO-1 was equally confined to the junction in both wild-type (g) and knock out mice (h). Differences in the pattern, as
shown for a microaneurysm (i), reflect the highly irregular endothelial organization at this site. Bars, 10 mm.The Journal of Cell Biology, Volume 153, 2001 550
and/or the placenta. The temporal occurrence of the vas-
cular phenotypes seen in the PDGF-B and PDGFR-b
knock outs (Fig 9 a) suggests that loss of paracrine/juxta-
crine PC-to-EC signaling promotes endothelial hyperpla-
sia, whereas the increased VEGF-A levels may contribute
to the progressive vascular derangement that become ap-
parent with increased embryonic age. A hypothetical sce-
nario for pathogenic cause–effect relationships in PDGF-B
and PDGFR-b knock outs is outlined in Fig. 9 b.
Lack of PCs Leads to EC Hyperplasia
Based on morphological studies, it has been proposed that
PCs control vessel sprouting and branching (Nehls et al.,
1992, 1994). Despite the near complete lack of PCs in the
PDGF-B and PDGFR-b knock out brains, we show that
blood vessels in this tissue have a normal number of
branch points and a normal microvessel density. However,
blood vessels devoid of PCs exhibit several other defects,
such as irregular diameter and increased permeability. In-
terestingly, mutant blood vessels show EC hyperplasia at
time points before any signs of systemic disease. Normally,
the first blood vessels sprout into the brain parenchyma
around E 10. EC hyperplasia in PDGF-B and PDGFR-b
knock outs was evident from E 11.5. At this time, PCs are
already present on the wild-type brain blood vessels but
are missing in the PDGF-B and PDGFR-b knock outs.
The temporal correlation between failure of PCs recruit-
ment and endothelial hyperplasia suggests that the lack of
PCs directly regulates EC number. Consistent with this,
coculture experiments have suggested that PC–EC contact
inhibits both EC and PC proliferation (Antonelli-Orlidge
et al., 1989; Hirschi et al., 1999). Morphological studies in-
dicate a negative correlation between the presence of PCs
and the proliferation of ECs in experimental and patho-
logical angiogenesis (Cogan et al., 1961; Kuwabara and
Cogan, 1963; Crocker et al., 1970; Benjamin et al., 1999).
Pericytic Influence on Capillary Morphogenesis
Although it is plausible that the EC hyperplasia in PDGF-B
and PDGFR-b embryos may contribute to an increased
capillary diameter, the reduced EC junctional circumfer-
ence and the increased EC cytoplasmic thickness suggest
Figure 8. Freeze fracture replicas of brain capillary tight junc-
tions of wild-type (a) and PDGF-B knock out (b) embryos at E
18.5. The tight junction particles were mostly associated to the
external membrane leaflet (E) and only sparsely distributed on
the protoplasmic membrane leaflet (P) in both the wild type and
the knock out. The complexity of the junctional network as
judged by the branching frequency of the strands was similar be-
tween wild type and PDGF-B knock out. Bars, 100 nm.
Figure 9. (a) Occurrence of
phenotypes in the PDGF-B
and PDGFR-b knock out
embryos. The lack of PCs in
PDGF-B and PDGFR-b
knock out embryos coin-
cides with the EC hyperpla-
sia at E 11.5. At E 13.5, the
first morphological signs of
the placenta defects are evi-
dent, and this is also when an
upregulation of VEGF-A is
detected. Subsequently mi-
croaneurysms develop, and
at late gestation, the embryos
are edematous. (b) Hypo-
thetical pathogenic cause–
effect relationships in
PDGF-B and PDGFR-b
knock outs. Causal links sup-
ported by strong experimen-
tal evidence or extensive cor-
relative data are depicted by
thick red arrows. Causal
links, which are plausible but
lack or have only limited ex-
perimental support, are de-
picted with thin blue arrows.
PDGF-B and PDGFR-b are
required for the longitudinal
recruitment of PCs to newly
formed blood vessels, and
lack of PCs leads to microvessel abnormalities (1 and 2) (Levéen
et al., 1994; Soriano, 1994; Lindahl et al., 1997; Hellstrom et al.,
1999; Ohlsson et al., 1999). Deficient blood vessel development
in the placenta leads to improper placenta function (3) (Ohlsson
et al., 1999; Ihle, 2000), which might promote hypoxia/hypoglyce-
mia–induced VEGF-A, leading to microvessel abnormalities (4)
(this report; Benjamin et al., 1998). The heart defect in the
PDGF-B and PDGFR-b knock outs might stem from the abnor-
mal heart vasculature or be due to placenta defects (5 and 6)
(Barak et al., 1999; Hellstrom et al., 1999; Ihle, 2000).Hellström et al. Vascular Morphogenesis in the Absence of Pericytes 551
that ECs are more crowded in the microvessel wall. An av-
erage 25% increase in vessel diameter, as seen in the mu-
tants, would result on average in a two times increase in
tension in the vascular wall at constant blood pressure.
This could, by itself or in combination with the lack of the
structural support from PCs, promote microaneurysm for-
mation. A schematic illustration of the capillary EC phe-
notype in the PDGF-B/PDGFR-b knock outs is shown in
Fig. 10.
The cause of the luminal EC projections seen in the mu-
tants is currently poorly understood. A similar ultrastruc-
tural EC phenotype has been described for the fibulin-1
knock out (Kostka, G., and R. Timpl, personal communi-
cation). Fibulin-1 is a component of the vascular basement
membrane shared between ECs and PCs and could, ac-
cordingly, be of importance for the normal EC–PC inter-
action. During the development of the pecten oculi of the
chick eye, there is degeneration and loss of PCs (Gerhardt
et al., 2000). This is accompanied by an increase in EC
number and the formation of excessive luminal EC projec-
tions. Thus, a role for PCs in controlling EC proliferation
and morphology is suggested also from a normal develop-
mental process in the chick eye.
Endothelial Hyperplasia Precedes 
VEGF-A Upregulation
VEGF-A is a potent endothelial mitogen critical for em-
bryogenesis (for review see Ferrara, 1999). A narrow
range of VEGF concentration is required for normal car-
diovascular development, since a 50% reduction or a two-
to threefold increase in VEGF-A expression both lead to
embryonic lethality in mice (Carmeliet et al., 1996; Ferrara
et al., 1996; Gerber et al., 1999; Miquerol et al., 2000). We
found that VEGF-A levels were upregulated more than
twofold in PDGF-B and PDGFR-b knock out embryos at
late gestation. However, VEGF-A was not significantly
upregulated at the earliest time points of EC hyperplasia
in mutants but became progressively elevated from E 13.5
on. Although an increased expression of VEGF-A does
not seem to explain the EC hyperplasia in the knock outs
before E 13.5, VEGF-A may support the hyperplastic
state later. In a model of regulated VEGF expression in
tumors, Benjamin and co-workers (1999) demonstrated
that VEGF withdrawal leads to selective EC apoptosis
and degeneration of tumor vessels lacking PC/vSMCs.
Their study suggests that either VEGF or contact with PC/
vSMCs is sufficient to promote EC survival in tumor ves-
sels. In analogy with their study, the absence of PCs in
PDGF-B and PDGFR-b knock out brains may be com-
pensated by increased VEGF-A levels, allowing for sur-
vival of the increased number of ECs.
Upregulation of VEGF-A and Other Markers of 
Metabolic Stress Suggests Systemic Defects in 
PDGF-B and PDGFR-b Knock Outs
VEGF-A is induced by hypoxia and hypoglycemia both at
the RNA and protein levels (Shweiki et al., 1992; Stein et
al., 1998). Upregulation of VEGF-A, Glut-1, GRP-78,
LDH, and PGK suggests that PDGF-B and PDGFR-b
knock out embryos are influenced by metabolic stress.
Several causes of hypoxia and/or hypoglycemia in these
knock outs can be envisioned. First, it might originate
from low tissue oxygenation due to malfunctioning mi-
crovessels. Second, the labyrinthine layer of the placenta
has a reduced number of PCs and trophoblasts in PDGF-B
and PDGFR-b knock outs, which results in dilated embry-
onic vessels and in a reduced fetal–maternal interface
(Ohlsson et al., 1999). This might result in inefficient ex-
change between the fetal and maternal blood vessels, lead-
ing to shortage of oxygen and nutrients and accumula-
tion of waste products in mutant embryos. It is interesting
to note that the earliest morphological signs of pla-
centa defects in mutants occur at E 13.5, coincident
with the increased VEGF-A levels. Third, the PDGF-B
and PDGFR-b knock out hearts are dilated and hypo-
trophic, which may have systemic consequences (Levéen
et al., 1994; Hellstrom et al., 1999). A scenario for the
pathogenic cause–effect relationships in PDGF-B and
PDGFR-b knock outs is outlined in Fig. 9 b.
Vascular Leakage Is Accompanied by Elevated 
Vesiculation and Altered Junctional Architecture
The edema in late PDGF-B and PDGFR-b mutant em-
bryos prompted us to analyze markers of EC junctions and
transcellular transport. Vesicular transport by caveolae is
a major pathway for transcellular permeability (for review
see Feng et al., 1999). The increase in caveolae and caveo-
lin-1 staining seen in PDGF-B and PDGFR-b mutants
suggests that this may cause (a portion of) the vascular
leakage in these embryos.
Paracellular transport is controlled by tight and adher-
ens junctions. Tight junctions are built up by lipids and
transmembrane proteins, which are anchored to the cyto-
skeleton (for review see Kniesel and Wolburg, 2000).
Figure 10. Schematic illustra-
tion of wild-type and knock
out capillaries based on the
combined data of morpholog-
ical, morphometric, and im-
munocytochemical analysis.
The absence of PCs in the
PDGF-B and PDGFR-b
knock outs leads to blood ves-
sel dilation, EC hyperplasia,
and microaneurysm forma-
tion. The ECs exhibit luminal
membrane folding and highly
variable cytoplasmic thick-
ness and size.The Journal of Cell Biology, Volume 153, 2001 552
Freeze fracture analysis of the endothelial tight junctions
revealed no differences between the wild type and the
PDGF-B knock out. However, the transmembrane pro-
tein, occludin, was redistributed and showed less distinct
tight junctional staining in the PDGF-B and PDGFR-b
knock outs. The series of events leading to the develop-
mental acquisition of blood–brain barrier properties in
ECs has been described to involve the shift of occludin
from cytoplasmic pools to the tight junctions (Gerhardt et
al., 1999). Accordingly, the elevated cytoplasmic and re-
duced junctional localization of occludin in the knock outs
may be interpreted as a sign of less mature tight junctions.
Similarly, the adherens junction protein VE-cadherin was
partially redistributed from a junctional to a cytoplasmic
location. Together, this suggests that tight and adherens
junctions are formed in knock outs but do not exhibit the
full degree of differentiation. It is known that VEGF-A
promotes both paracellular and transcellular permeability
in ECs by increasing the number of caveolae and by rear-
ranging occludin and VE-cadherin (Vasile et al., 1999). It
is therefore possible that the increased levels of VEGF-A
directly induce vascular leakage in the PDGF-B and
PDGFR-b knock outs. This idea is strengthened by the
fact that there are no differences in caveolin-1, occludin, or
VE-cadherin staining at E 12.5, when VEGF-A is not yet
upregulated, and no increase in vascular leakage has been
observed in the mutants. Furthermore, high expression of
VEGF-A has been correlated with leaky blood vessels in
several experimental and pathological conditions (for re-
views see Dvorak et al., 1999; Ferrara and Alitalo, 1999).
The vascular leakage in the PDGF-B and PDGFR-b
knock out brains is likely a major cause of edema and glial
swelling. This could be the trigger of the upregulation of
the astrocyte-specific water channel aquaporin-4 (Wen et
al., 1999) in glial cells surrounding the abnormal blood
vessels in PDGF-B and PDGFR-b knock outs, which is
consistent with aquaporin-4 upregulation in other condi-
tions where vascular leakage and brain edema is promi-
nent (Vajda et al., 2000).
In summary, our analysis suggests that PCs regulate EC
number during embryonic angiogenesis. Elevated VEGF-
A levels, possibly secondary to systemic metabolic stress in
PDGF-B and PDGFR-b knock outs, may also contribute
to the vascular abnormalities seen in these embryos, in
particular to the increased vascular leakage observed at
late gestation. Our analyses suggest that the pathogenesis
of vascular abnormalities also in other mouse mutants is
complex and may depend on a combination of local cues,
e.g., mechanical properties or signaling events, and sec-
ondary systemic influences (Fig. 9 b). The number of
mouse knock outs with lethal cardiovascular syndromes
available for analysis is steadily increasing, but for most of
these, the understanding is still rather poor. The determi-
nation of pathogenic chains of events in these mutants is
challenging but may also have important implications for
the understanding of microvessel disease in humans, such
as diabetic microangiopathy.
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